Nano antibody for resisting novel coronavirus and variant thereof as well as preparation method and application of nano antibody

A technology of nano-antibody and coronavirus, applied in the field of biomedicine, to achieve the effects of reducing production costs, simple transformation of multi-combination forms, and wide application range

Active Publication Date: 2022-07-22
SHENZHEN UNIV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of this application is to provide a nanobody against novel coronavirus and its variants and its preparation method and application, aiming at solving the lack of a nanobody that can effectively combine with novel coronavirus and its variants in the prior art. antibody problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nano antibody for resisting novel coronavirus and variant thereof as well as preparation method and application of nano antibody
  • Nano antibody for resisting novel coronavirus and variant thereof as well as preparation method and application of nano antibody
  • Nano antibody for resisting novel coronavirus and variant thereof as well as preparation method and application of nano antibody

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0045] A second aspect of the embodiments of the present application provides a method for preparing a nanobody against a novel coronavirus and a variant thereof, comprising the following steps:

[0046] S01. Provide the target protein antigen, coat the target protein antigen on the immune tube and combine with the phage library to obtain the target protein antigen-phage library;

[0047] S02. The target protein antigen-phage library is eluted to obtain an eluate, and the eluate is mixed with the helper phage for enrichment screening, and monoclonal antibody screening to obtain specific nanobody sequences;

[0048] S03. Clone the specific nanobody sequence into an expression vector to obtain a recombinant plasmid, transfer the recombinant plasmid into a host cell to induce expression and purify to obtain a nanobody targeting the new coronavirus.

[0049] The second aspect of the examples of the present application provides a method for preparing a nanobody against a novel coro...

Embodiment 1

[0111] Nanobody Nb-H6 against novel coronavirus and its variant strain and preparation method thereof

[0112] preparation methods such as figure 1 shown, as follows:

[0113] 1. Amplification and titration of natural library:

[0114] 1) pick E. coli The TG1 monoclonal strain was cultured in 100 mL of 2×YT medium containing 10 mg / L Tet at 37°C and shaken at 200 rpm to the logarithmic growth phase (OD 600 nm = 0.5);

[0115] 2) Add 100 μL to 200 μL of the VHH phage natural library stored at -20°C to 1. E. coli In TG1 bacterial solution, incubate at 37°C for 1 h;

[0116] 3) Add 400 mL of 2×YT (containing 2% glucose, 100 mg / L Amp), shake at 37°C and cultivate at 200 rpm until OD600 nm = 0.5, then add the helper phage M13KO7 (the final concentration is 10 10 pfu / mL), incubate at 37°C for 1 h;

[0117] 4) Centrifuge the above-mentioned 500 mL bacterial solution at 6000 rpm for 15 min, discard the supernatant (remove glucose, free phage and free helper phage), and take ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention relates to the technical field of biological medicines, in particular to a nano antibody for resisting a novel coronavirus and a variant thereof as well as a preparation method and application of the nano antibody, and provides a nano antibody Nb-H6 which can specifically aim at the novel coronavirus and a variant S1 thereof, can effectively inhibit the combination of S1 protein and ACE2, can effectively neutralize the combination of SARS-CoV-2 pseudovirus and ACE2, and can be used for preparing a novel coronavirus-resistant nano antibody. Therefore, viruses are prevented from entering and infecting cells; and meanwhile, the Nb-H6 has very good affinity with Delta, Alpha and Omicron mutants, so that the Nb-H6 is beneficial to wide application.

Description

technical field [0001] The present application belongs to the technical field of biomedicine, and in particular relates to a nanobody against a novel coronavirus and its variant strains, as well as a preparation method and application thereof. Background technique [0002] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, SARS-CoV-2 for short) is the causative agent of the coronavirus disease 2019 (COVID-19) that is currently ravaging the world. As of May 18, 2022, World Health Organization (WHO) statistics show that globally, COVID-19 has caused more than 520 million confirmed cases and 6.2 million deaths. The new coronavirus is a single-stranded RNA virus of the β-coronaviridae family. Its RNA genome encodes four major structural proteins: Spike protein (S), Nucleocapsid protein (N), and transmembrane protein. (Membraneprotein, M) and envelope protein (envelope protein, E). The study found that the S protein is responsible for attachment to the host cell surfa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/10C12N15/70G01N33/569
CPCC07K16/10C12N15/70G01N33/56983C07K2317/569C07K2317/565C07K2317/567G01N2333/165Y02A50/30
Inventor 叶亮吴丹丹
Owner SHENZHEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products